Alt i norske vitenarkiv i én tjeneste (NORA)
Filter
Search
  1. Low expression levels of ATM may substitute for CHEK2/TP53 mutations predicting resistance towards anthracycline and mitomycin chemotherapy in breast cancer
    (2012)
    - BMC
    • Knappskog, Stian
    • Chrisanthar, Ranjan
    • Løkkevik, Erik
    (and 8 more...)

    Knappskog, Stian

    Chrisanthar, Ranjan

    Løkkevik, Erik

    Anker, Gun Birgitta

    Østenstad, Bjørn

    Lundgren, Steinar

    Risberg, Terje

    Mjaaland, Ingvil

    Leirvaag, Beryl

    Miletic, Hrvoje

    Lønning, Per Eystein

    - Tidsskriftsartikkel
    - inMunin
  2. Low expression levels of ATM may substitute for CHEK2/TP53 mutations predicting resistance towards anthracycline and mitomycin chemotherapy in breast cancer
    (2012)
    - BMC
    • Knappskog, Stian
    • Chrisanthar, Ranjan
    • Løkkevik, Erik
    (and 8 more...)

    Knappskog, Stian

    Chrisanthar, Ranjan

    Løkkevik, Erik

    Anker, Gun Birgitta

    Østenstad, Bjørn

    Lundgren, Steinar

    Risberg, Terje

    Mjaaland, Ingvil

    Leirvaag, Beryl

    Miletic, Hrvoje

    Lønning, Per Eystein

    • Tidsskriftsartikkel
    • Tidsskriftsartikkel
    - inNTNU Open
  3. Persistence of disseminated tumor cells after neoadjuvant treatment for locally advanced breast cancer predicts poor survival
    (2012)
    - BMC (part of Springer Nature)
    • Mathiesen, Randi Margit Ruud
    • Borgen, Elin
    • Renolen, Anne
    (and 10 more...)

    Mathiesen, Randi Margit Ruud

    Borgen, Elin

    Renolen, Anne

    Løkkevik, Erik

    Nesland, Jahn M

    Anker, Gun Birgitta

    Østenstad, Bjørn

    Lundgren, Steinar

    Risberg, Terje

    Mjaaland, Ingvil

    Kvalheim, Gunnar

    Lønning, Per Eystein

    Naume, Bjørn

    • Tidsskriftsartikkel
    • Tidsskriftsartikkel
    - inNTNU Open
  4. Prognostic value of metabolic response in breast cancer patients receiving neoadjuvant chemotherapy
    (2012)
    - BioMed Central
    • Cao, Maria Dung
    • Giskeødegård, Guro F.
    • Bathen, Tone Frost
    (and 5 more...)

    Cao, Maria Dung

    Giskeødegård, Guro F.

    Bathen, Tone Frost

    Sitter, Beathe

    Bofin, Anna M.

    Lønning, Per Eystein

    Lundgren, Steinar

    Gribbestad, Ingrid S

    • Tidsskriftsartikkel
    • Tidsskriftsartikkel
    - inNTNU Open
  5. Persistence of disseminated tumor cells after neoadjuvant treatment for locally advanced breast cancer predicts poor survival
    (2012)
    - BMC
    • Mathiesen, Randi Margit Ruud
    • Borgen, Elin
    • Renolen, Anne
    (and 10 more...)

    Mathiesen, Randi Margit Ruud

    Borgen, Elin

    Renolen, Anne

    Løkkevik, Erik

    Nesland, Jahn M

    Anker, Gun Birgitta

    Østenstad, Bjørn

    Lundgren, Steinar

    Risberg, Terje

    Mjaaland, Ingvil

    Kvalheim, Gunnar

    Lønning, Per Eystein

    Naume, Bjørn

    - Tidsskriftsartikkel
    - inMunin
  6. MDM2 Promoter SNP344T>A (rs1196333) Status Does Not Affect Cancer Risk
    (2012)
    - Public Library of Science (PLoS)
    • Knappskog, Stian
    • Gansmo, Liv Beathe
    • Romundstad, Pål Richard
    (and 12 more...)

    Knappskog, Stian

    Gansmo, Liv Beathe

    Romundstad, Pål Richard

    Bjørnslett, Merete Pauline

    Trovik, Jone

    Sommerfelt-Pettersen, Jan

    Løkkevik, Erik

    Tollenaar, Rob A.E.M.

    Seynaeve, Caroline

    Devilee, Peter

    Salvesen, Helga Birgitte

    Dørum, Anne

    Hveem, Kristian

    Vatten, Lars Johan

    Lønning, Per Eystein

    Tidsskriftsartikkel
    - inDUO
  7. MDM2 Promoter SNP344T>A (rs1196333) Status Does Not Affect Cancer Risk
    (2012)
    - Public Library of Science
    • Knappskog, Stian
    • Gansmo, Liv B.
    • Romundstad, Pål
    (and 4 more...)

    Knappskog, Stian

    Gansmo, Liv B.

    Romundstad, Pål

    Bjørnslett, Merete

    Trovik, Jone

    Lønning, Per Eystein

    Salvesen, Helga Birgitte

    • Tidsskriftsartikkel
    • Tidsskriftsartikkel
    - inBORA
  8. Effect of the MDM2 promoter polymorphisms SNP309T>G and SNP285G>C on the risk of ovarian cancer in BRCA1 mutation carriers
    (2012)
    - BioMed Central
    • Bjørnslett, Merete
    • Knappskog, Stian
    • Lønning, Per Eystein
    (and 1 more...)

    Bjørnslett, Merete

    Knappskog, Stian

    Lønning, Per Eystein

    Dørum, Anne

    • Tidsskriftsartikkel
    • Tidsskriftsartikkel
    - inBORA
  9. Low expression levels of ATM may substitute for CHEK2 / TP53 mutations predicting resistance towards anthracycline and mitomycin chemotherapy in breast cancer
    (2012)
    - BioMed Central
    • Knappskog, Stian
    • Chrisanthar, Ranjan
    • Løkkevik, Erik
    (and 8 more...)

    Knappskog, Stian

    Chrisanthar, Ranjan

    Løkkevik, Erik

    Anker, Gun Birgitta

    Østenstad, Bjørn

    Lundgren, Steinar

    Risberg, Terje

    Mjaaland, Ingvil

    Leirvaag, Beryl

    Miletic, Hrvoje

    Lønning, Per Eystein

    Tidsskriftsartikkel
    - inBORA
  10. Prognostic value of metabolic response in breast cancer patients receiving neoadjuvant chemotherapy
    (2012)
    - BioMed Central
    • Cao, Maria Dung
    • Giskeødegård, Guro F.
    • Bathen, Tone Frost
    (and 5 more...)

    Cao, Maria Dung

    Giskeødegård, Guro F.

    Bathen, Tone Frost

    Sitter, Beathe

    Bofin, Anna

    Lønning, Per Eystein

    Lundgren, Steinar

    Gribbestad, Ingrid S.

    Tidsskriftsartikkel
    - inBORA
  11. Persistence of disseminated tumor cells after neoadjuvant treatment for locally advanced breast cancer predicts poor survival
    (2012)
    - BioMed Central
    • Mathiesen, Randi Margit Ruud
    • Borgen, Elin
    • Renolen, Anne
    (and 10 more...)

    Mathiesen, Randi Margit Ruud

    Borgen, Elin

    Renolen, Anne

    Løkkevik, Erik

    Nesland, Jahn M.

    Anker, Gun

    Østenstad, Bjørn

    Lundgren, Steinar

    Risberg, Terje

    Mjaaland, Ingvil

    Kvalheim, Gunnar

    Lønning, Per Eystein

    Naume, Bjørn

    Tidsskriftsartikkel
    - inBORA